Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Banvit Bandirma Vitaminli Yem Sanayi AS TRY 23.62, price TRY 133, upside -82.3%, quality 26 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Banvit Bandirma Vitaminli Yem Sanayi AS for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 54.95 TRY – 437.50 TRY · fair‑value band 15.59 TRY – 29.53 TRY · the 133.30 TRY price screens above the 23.62 TRY fair value. Dashed = 300-day average. As of Sep 24, 2026.
Follow Banvit Bandirma Vitaminli Yem Sanayi AS in your weekly email
Every Wednesday you see whether Banvit Bandirma Vitaminli Yem Sanayi AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi operates as a food company in Turkey. It engages in production, processing, sales, and marketing of feed, breeder eggs, day-old broiler chicks, live broilers, broiler meat, and further processed products. The company also exports its products. It distributes its products through the branches and dealers.
Show more
Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi operates as a food company in Turkey. It engages in production, processing, sales, and marketing of feed, breeder eggs, day-old broiler chicks, live broilers, broiler meat, and further processed products. The company also exports its products. It distributes its products through the branches and dealers. The company was incorporated in 1968 and is headquartered in Balikesir, Turkey. Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi is a subsidiary of BRF GmbH.
Stock analysis
Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) currently trades at 133.30 TRY, while our model-based Fair Value estimate is 23.62 TRY, 82.3% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.
Scenario range: 15.59 TRY (bear) to 29.53 TRY (bull), the price of 133.30 TRY sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 26/100 (below-average quality), in the Consumer Defensive sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Banvit Bandirma Vitaminli Yem Sanayi AS reported revenue of 33.5B TRY in FY2025 versus 5.3B TRY in FY2021, a compound +58.4%/yr. Reported net income was −3.1B TRY in FY2025.
Key figures
Market cap 15.5B TRY (≈ $315M) · P/S ratio 0.49 · EPS (TTM) −38.93 TRY · Net margin −9.3% · Return on equity −34.8% · Return on assets (EBIT) 6.7% · Operating margin −10.4% · Revenue (TTM) 31.3B TRY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 9% fair-value upside, at −82%, BANVT screens richer than that median.
Fair Value models
Bear 15.59 TRYFair Value 23.62 TRYBull 29.53 TRY
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.32/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−18.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+45.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+55.5%
Start year 2020 (pandemic). Over 10 years: +32.5% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1.9% (2020) → −8.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Banvit Bandirma Vitaminli Yem Sanayi AS with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 634 stocks
Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score32 · Bottom 25%
Fair Value upside−82.3% · Bottom 25%
Profitability
Return on assets−11.8% · Bottom 25%
Net margin (TTM)−12.4% · Bottom 25%
Operating margin (TTM)−10.4% · Bottom 25%
Growth and dividend
Revenue growth−21.4% · Bottom 25%
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/S (TTM)0.01× · Cheapest 25%
PEG1.91× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)0· sector 21
PAST (return on equity)0· sector 31
HEALTH (low debt)100· sector 96
DIVIDEND (yield)0· sector 57
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Banvit Bandirma Vitaminli Yem Sanayi AS Fair Value". https://www.fairvalue-calculator.com/stock/BANVT
Frequently asked questions
Is Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 23.62 TRY versus a price of 133.30 TRY, about −82% upside (overvalued).
What is the fair value of BANVT?
Our model-based fair value for Banvit Bandirma Vitaminli Yem Sanayi AS is 23.62 TRY (as of Sep 24, 2026), built from audited fundamentals. The current price: 133.30 TRY.
What is the quality score of BANVT?
Banvit Bandirma Vitaminli Yem Sanayi AS has a Quality Score of 26/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Our model-based price target is the fair value of 23.62 TRY (as of Sep 24, 2026) from 1 valuation models. Cautious scenario 15.59 TRY, optimistic scenario 29.53 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Banvit Bandirma Vitaminli Yem Sanayi AS stock forecast for 2026?
Our models put fair value at 23.62 TRY, about −82% upside versus a price of 133.30 TRY (overvalued). Cautious scenario 15.59 TRY, optimistic scenario 29.53 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Banvit Bandirma Vitaminli Yem Sanayi AS reported trailing-twelve-month revenue of about 31.3B TRY (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Banvit Bandirma Vitaminli Yem Sanayi AS it is 23.62 TRY per share (as of Sep 24, 2026), against a price of 133.30 TRY. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Banvit Bandirma Vitaminli Yem Sanayi AS stock overvalued or undervalued in 2026?
As of Sep 24, 2026, BANVT trades above its calculated fair value: price 133.30 TRY, fair value 23.62 TRY, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BANVT?
No. The price is what the market pays today (133.30 TRY); the fair value is what the company's own numbers justify (23.62 TRY). For Banvit Bandirma Vitaminli Yem Sanayi AS the two are 109.68 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Banvit Bandirma Vitaminli Yem Sanayi AS worth?
The market values Banvit Bandirma Vitaminli Yem Sanayi AS at about 15.5B TRY (market capitalisation, as of Sep 24, 2026). Per share that is 133.30 TRY; our models calculate a fair value of 23.62 TRY per share.
What do the bullish and bearish scenarios say about BANVT?
Our models span a range for Banvit Bandirma Vitaminli Yem Sanayi AS: cautious scenario 15.59 TRY, base 23.62 TRY, optimistic 29.53 TRY per share (as of Sep 24, 2026, price 133.30 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of BANVT?
The PEG ratio of Banvit Bandirma Vitaminli Yem Sanayi AS is 1.91 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Balance-sheet figures for Banvit Bandirma Vitaminli Yem Sanayi AS (as of Sep 24, 2026): return on equity −34.8%, debt of 0.00 per unit of equity. They feed the Quality Score of 26/100, which measures business quality independently of the share price.
How far is BANVT from its 52-week high?
Banvit Bandirma Vitaminli Yem Sanayi AS trades at 133.30 TRY, about 28% below its 52-week high of 185.70 TRY and 5% above the low of 127.40 TRY (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 23.62 TRY is for.
Which stocks are comparable to Banvit Bandirma Vitaminli Yem Sanayi AS?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Banvit Bandirma Vitaminli Yem Sanayi AS stock attractive at the current price?
The data as of Sep 24, 2026: price 133.30 TRY, calculated fair value 23.62 TRY (−82%), Quality Score 26/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BANVT calculated?
We run Banvit Bandirma Vitaminli Yem Sanayi AS through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 23.62 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Banvit Bandirma Vitaminli Yem Sanayi AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The closing price on Oct 2, 2026 was 133.30 TRY. Our model-based fair value is 23.62 TRY, about −82% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Banvit Bandirma Vitaminli Yem Sanayi AS right now?
The price sits above even our optimistic bull case (29.53 TRY). The favourable scenario is already priced in. Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (15.59 TRY to 29.53 TRY) leaves room in how you read the outcome.
Key figures of Banvit Bandirma Vitaminli Yem Sanayi AS
How large is the market capitalisation of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The market capitalisation of Banvit Bandirma Vitaminli Yem Sanayi AS is 15.5B TRY (≈ $315M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The price-to-sales ratio of Banvit Bandirma Vitaminli Yem Sanayi AS is 0.49 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Earnings per share at Banvit Bandirma Vitaminli Yem Sanayi AS are −38.93 TRY. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The net margin of Banvit Bandirma Vitaminli Yem Sanayi AS is −9.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The return on equity (ROE) of Banvit Bandirma Vitaminli Yem Sanayi AS is −34.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
On an EBIT basis the return on assets of Banvit Bandirma Vitaminli Yem Sanayi AS is 6.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The operating margin of Banvit Bandirma Vitaminli Yem Sanayi AS is −10.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Revenue at Banvit Bandirma Vitaminli Yem Sanayi AS is growing −21.4% versus a year earlier (3y avg +45.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Earnings per share at Banvit Bandirma Vitaminli Yem Sanayi AS are growing +64.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) generate?
The free cash flow of Banvit Bandirma Vitaminli Yem Sanayi AS is −23.4B TRY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) carry?
The net debt of Banvit Bandirma Vitaminli Yem Sanayi AS is 209M TRY (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Banvit Bandirma Vitaminli Yem Sanayi AS in the live analysis
One click puts Banvit Bandirma Vitaminli Yem Sanayi AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
